Key Development: February 2026: The Phase 3 TRIUMPH-1 trial results for orforglipron showed a mean body weight reduction of 14.7% at 36 weeks in adults with obesity without diabetes, according to Eli Lilly and Company
Symptoms may include: stomach area swelling fullness, gas in the stomach area abdominal pain and cramping breath odor constipation diarrhea inability to pass gas vomiting What to do If you experience stomach side effects with this medicine that bother you, worsen or do not go away, call your healthcare provider right away for further evaluation
The strength of the evidence in GLP-1 NAION lawsuits as really increased in the last six months
The FDA does not recommend routine calcitonin measurement or thyroid ultrasound screening, as these have uncertain value and are not recommended for patients taking GLP-1 receptor agonists
L-carnitine minimizes muscle damage by limiting oxidative stress, making it easier for your body to bounce back after a tough workout
5 For someone living with established cardiovascular disease, this is a real difference between the two medications